Huntington’s disease research news. In plain language. Written by scientists. For the global HD community.

We’ve been following the development of uniQure’s HTT-lowering drug, AMT-130, from its genesis in the lab, to animal studies just a few years ago, and now through to their ongoing Phase 1/2 clinical ...

COVID-19 update: what does it mean for HD families, how does it impact HD research, and how has it changed the way science works? Wave Life Sciences announces that its antisense drug WVE-120102 has ...

Announcing the 2025 HDBuzz Prize for Young Science Writers – sponsored by the Hereditary Disease Foundation!

HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD ...